What should you know about ependymoma immunohistochemistry?

After tissue is obtained, a pathologist examines its architecture and applies selected antibodies to tissue sections. The resulting pattern can help distinguish ependymoma from other tumours that may occur near the brain or spinal cord. Reports may mention markers such as GFAP, epithelial membrane antigen, or other features, including whether staining has a characteristic dot-like or surface distribution. These observations are weighed with the microscope appearance, imaging, tumour location, and when needed, molecular classification. A stain is evidence within a diagnostic process, not a stand-alone label.

Ask for the integrated pathology diagnosis and whether molecular testing was performed or recommended. Clarify the tumour location, grade or classification used by the team, and whether the sample was sufficient for the planned analysis. Keep copies of the pathology and imaging reports for consultations. Treatment planning may involve neurosurgery, radiotherapy, or surveillance, depending on the tumour's location, extent, symptoms, and the person’s overall health.

Get urgent help for a new seizure, sudden weakness, severe headache with vomiting, confusion, loss of consciousness, or rapidly worsening balance. After a biopsy or operation, fever, wound drainage, worsening swelling, or a severe change in alertness also needs prompt clinical review.

Which stains support or challenge ependymoma? Was molecular classification completed? What does the integrated report say about grade and location? How will the result guide surgery, radiotherapy, or monitoring?